Prof. Giovanni Ceccarini will address the treatment options for lipodystrophy, discussing results with traditional diabetological and lipid lowering therapies, and illustrate the efficacy and safety profile of leptin replacement therapy with metreleptin, focusing on partial lipodystrophy patients.